Delivery Order SPE2DR25D3015-SPE2DR26F4GL0
- Not listed
- The Defense Logistics Agency awarded a $15,452.14 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Ondansetron ODT 8 mg tablets (30-count units), with an ultimate completion date of January 8, 2026. This non-set-aside contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $5,618.36 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery...
- The Defense Logistics Agency awarded a delivery order valued at $32,253.76 to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Ondansetron ODT 8mg tablets in a 30-count package. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of February 4, 2026. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency awarded a delivery order valued at $21,043.11 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count units). The contract is a firm fixed-price, non-set-aside award with a completion date of January 15, 2026, and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $5,724.72 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This firm fixed-price delivery order, which is set to be completed by January 7, 2026, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's capability to compete on a full...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $3,228.06 delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packaging). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 24, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. The contract contains no set-aside designation and represents a discrete pharmaceutical delivery fulfilling federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,618.73 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on December 4, 2025, with completion scheduled for December 5, 2025. The award is a firm fixed price delivery order with no set-aside designation, indicating competitive selection. Performance will be executed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,151.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 4 mg tablets (30-count supply) on January 13, 2026, with an ultimate completion date of January 14, 2026. This contract was awarded without a set-aside designation on a competitive basis and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company Cencora,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Ondansetron ODT 8 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $4,328.04 under firm fixed-price terms, with an ultimate completion date of July 31, 2025. The pharmaceutical products will be delivered to the contracting location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Ondansetron ODT 8 mg tablets (30-count units) with a ceiling value of $26,647.13. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, is set for ultimate completion by December 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single task under AmerisourceBergen's...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4GL0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,903.79 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count) on January 16, 2026, with a completion date of January 20, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The order represents a task issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999,999,999.00 through December 31, 2031, and serves as the primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains extensive capabilities in supplying medications across multiple therapeutic domains to military treatment facilities and other federal healthcare systems. The ondansetron product being delivered under this order is a commonly used antiemetic medication essential for military and veteran healthcare operations. The company's federal contract portfolio demonstrates consistent performance in fulfilling competitively awarded orders through its IDC vehicle with DLA, which encompasses specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies supporting the Defense Health Agency and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 1/15/26 |